Legal News
Another shareholder sues Abiomed
Cyberonics gains on lawsuit dismissal
Shares of Cyberonics (NSDQ:CYBX) are up some 6% today after the medical device company said an ex-sales rep voluntarily dismissed a wrongful termination lawsuit.
Andrew Hagerty sued the Houston, Texas-based company last August, alleging that Cyberonics canned him after he refused to sell unneeded replacement batteries for implanted pulse generators designed to treat epilepsy.
Bard slides despite Street-beating Q4, 2012
Saying they plan to use an expected $1 billion windfall from a legal win over rival W.L. Gore & Assoc. to drive growth, executives with C.R. Bard (NYSE:BCR) detailed 4th-quarter and 2012 results that handily beat expectations on Wall Street.
Still, investors sent BCR shares down some 2.3% this morning, to $99.70 apiece as of about 11:40 a.m.
Patient takes the stand in Johnson & Johnson mesh lawsuit | MassDevice.com On Call
MASSDEVICE ON CALL —Plaintiff Linda Gross took the stand this week in a bellwether trial against Johnson & Johnson (NYSE:JNJ) subsidiary Ethicon’s transvaginal mesh implants.
ArthroCare DOJ beef gets a new deadline
Surgical devices maker ArthroCare (NSDQ:ARTC) this month agreed to extend for 1 more month the statute of limitations on a federal inquiry from the U.S. Dept. of Justice in to the company’s spinal business.
Zimmer loses bid to deny bellwether case in NextGen knee implant lawsuits
U.S. Customs seized $83M worth of counterfeit medical devices, drugs in 2012
Spanish court denies Zeltiq, Mass. General in patent suit against Clinipro
Zeltiq (NSDQ:ZLTQ) said the Mercantile Court in Spain denied its bid for a preliminary injunction against Clinipro in a joint lawsuit filed with Mass. General Hospital against the French medical aesthetics company.
Zeltiq and MGH sued Clinipro last year in France and Spain, alleging infringement of 2 patents for its CoolSculpting device.
Legal: W.L. Gore wins bid to re-examine Bard’s stent-graft patents
J&J dodged years of warnings before recalling metal hips, lawsuit claims
New documents unveiled during trial proceedings don’t bode well for Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Orthopaedics.
Emails and internal memos suggest that the metal-on-metal hip maker for years hid concerns about the failure rates of its ASR implants, which are now the subject of a high-profile recall and thousands of patient injury lawsuits.